Gujarat Kidney and Super Speciality Quarterly Results for Trading Insights
In Sept 2025, Gujarat Kidney and Super Speciality (GKSL) reported revenue ₹13 Cr and net profit ₹3 Cr — revenue +44.4% YoY. Compare with GKSL fair value to assess whether the stock is under or overvalued.
GKSL Quarterly Results — Revenue, Profit & EPS Highlights
Gujarat Kidney and Super Speciality latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. Also explore GKSL price movement history to track price trends across different timeframes.
- Revenue of ₹13 Cr in Sept 2025 (+30.0% vs Mar 2025, +44.4% vs Sept 2024)
- Net Profit of ₹3 Cr in Sept 2025 (+200.0% vs Mar 2025, +0.0% vs Sept 2024)
- EBITDA of ₹5 Cr in Sept 2025 (+66.7% vs Mar 2025)
- Operating Margin of 40.0% in Sept 2025 (+13.0pp vs Mar 2025)
- Earnings Per Share of ₹0.47 in Sept 2025 (+113.6% vs Mar 2025)
Gujarat Kidney and Super Speciality Quarterly Results — Revenue, EBITDA, Net Profit & EPS
GKSL quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.
| Metric | Sept 2025 | Mar 2025 | Jun 2025 | Dec 2025 | Sept 2024 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 13 | 10 | 15 | 23 | 9 | 30.0% | 44.4% |
| Net Profit (₹ Cr) | 3 | 1 | 5 | 4 | 3 | - | - |
| EBITDA (₹ Cr) | 5 | 3 | 9 | 7 | 5 | - | - |
| EPS (₹) | 0.47 | 0.22 | 0.85 | 0.52 | 0.65 | - | - |
| Operating Margin (%) | 40.0% | 27.0% | 57.0% | 30.0% | 52.0% | - | - |
GKSL Share Price Trend — 1-Year Movement Across Quarterly Results
Gujarat Kidney and Super Speciality 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. For annual financials, live price and key ratios, visit Gujarat Kidney and Super Speci screener.
Revenue Trend (₹ Cr)
Net Profit Trend (₹ Cr)
Operating Margin Trend (%)
GKSL vs Healthcare Services Peers — Quarterly Revenue, Profit & Market Cap
Gujarat Kidney and Super Speciality latest quarter revenue and net profit vs Healthcare Services competitors — market cap, price and earnings comparison.
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Apollo Hospitals
Sept 2025 |
₹115,322.48 Cr | 8308.5 | 6,365 | 494 | +12.4% | - | 7.8% | 250.3 |
|
Max Healthcare Inst…
Sept 2025 |
₹102,188.91 Cr | 1091.1 | 2,168 | 491 | +10.8% | - | 22.6% | 216.1 |
|
Fortis Healthcare
Sept 2025 |
₹72,751.54 Cr | 967.3 | 2,381 | 329 | +17.2% | - | 13.8% | 227.1 |
|
Aster DM Healthcare
Mar 2026 |
₹39,048.19 Cr | 759.3 | 1,219 | 154 | -0.6% | +18.1% | 12.6% | 279.1 |
|
Narayana Hrudayalaya
Sept 2025 |
₹37,624.87 Cr | 1930.9 | 1,668 | 259 | +11.0% | - | 15.5% | 151.8 |
All amounts in ₹ Crores